These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 10404811

  • 1. The effect of estradiol and a combined estradiol/progestagen preparation on insulin sensitivity in healthy postmenopausal women.
    Duncan AC, Lyall H, Roberts RN, Petrie JR, Perera MJ, Monaghan S, Hart DM, Connell JM, Lumsden MA.
    J Clin Endocrinol Metab; 1999 Jul; 84(7):2402-7. PubMed ID: 10404811
    [Abstract] [Full Text] [Related]

  • 2. The effects of sequential combined oral 17beta-estradiol norethisterone acetate on insulin sensitivity and body composition in healthy postmenopausal women: a randomized single blind placebo-controlled study.
    Walker RJ, Lewis-Barned NJ, Sutherland WH, Goulding A, Edwards EA, de Jong SA, Gold E, Walker HL.
    Menopause; 2001 Jul; 8(1):27-32. PubMed ID: 11201511
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effects on serum lipid and leptin levels of three different doses of norethisterone continuously combined with a fixed dose of 17beta-estradiol for nasal administration in postmenopausal women: a controlled, double-blind study.
    Castelo-Branco C, Palacios S, Vázquez F, Villero J, Ferrer J, Ascaso C, Balasch J.
    Fertil Steril; 2007 Aug; 88(2):383-9. PubMed ID: 17561009
    [Abstract] [Full Text] [Related]

  • 6. Lipids and clotting factors during low dose transdermal estradiol/norethisterone use.
    Brynhildsen J, Hammar M.
    Maturitas; 2005 Apr 11; 50(4):344-52. PubMed ID: 15780536
    [Abstract] [Full Text] [Related]

  • 7. Optimal tolerability of ultra-low-dose continuous combined 17beta-estradiol and norethisterone acetate: laboratory and safety results.
    Samsioe G, Hruska J, CHOICE Study Investigators.
    Climacteric; 2010 Feb 11; 13(1):34-44. PubMed ID: 20001563
    [Abstract] [Full Text] [Related]

  • 8. Effects of the route of estrogen administration on insulinlike growth factor-I, IGF binding protein-3, and insulin resistance in healthy postmenopausal women: results from a randomized, controlled study.
    Davis SR, Stuckey BG, Norman RJ, Papalia MA, Drillich A, Bell RJ.
    Menopause; 2008 Feb 11; 15(6):1065-9. PubMed ID: 18806686
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Monofluorophosphate combined with hormone replacement therapy induces a synergistic effect on bone mass by dissociating bone formation and resorption in postmenopausal women: a randomized study.
    Alexandersen P, Riis BJ, Christiansen C.
    J Clin Endocrinol Metab; 1999 Sep 11; 84(9):3013-20. PubMed ID: 10487657
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effects of oral and transdermal oestrogen replacement therapy on plasma levels of insulin-like growth factors and IGF binding proteins 1 and 3: a cross-over study.
    Helle SI, Omsjø IH, Hughes SC, Botta L, Hüls G, Holly JM, Lønning PE.
    Clin Endocrinol (Oxf); 1996 Dec 11; 45(6):727-32. PubMed ID: 9039339
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Low-dose hormone therapy and carbohydrate metabolism.
    Li C, Samsioe G, Borgfeldt C, Bendahl PO, Wilawan K, Aberg A.
    Fertil Steril; 2003 Mar 11; 79(3):550-5. PubMed ID: 12620438
    [Abstract] [Full Text] [Related]

  • 20. Effects of oral continuous 17beta-estradiol plus norethisterone acetate replacement therapy on abdominal subcutaneous fat, serum leptin levels and body composition.
    Yüksel H, Odabaşi AR, Demircan S, Karul A, Kozaci LD, Köseoğlu K, Kizilkaya K, Başak O.
    Gynecol Endocrinol; 2006 Jul 11; 22(7):381-7. PubMed ID: 16864148
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.